VOYA Investment Management
ABCL icon

VOYA Investment Management’s AbCellera Biologics ABCL Stock Holding History

VOYA Investment Management’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,624,185
Closed -$23.7M – 2648
2025
Q1 		$23.7M Hold
10,624,185
– – 0.03% 477
2024
Q4 		$31.1M Hold
10,624,185
– – 0.03% 419
2024
Q3 		$27.6M Hold
10,624,185
– – 0.03% 470
2024
Q2 		$31.4M Hold
10,624,185
– – 0.03% 418
2024
Q1 		$48.1M Hold
10,624,185
– – 0.05% 340
2023
Q4 		$60.7M Hold
10,624,185
– – 0.06% 304
2023
Q3 		$48.9M Hold
10,624,185
– – 0.05% 329
2023
Q2 		$68.6M Sell
10,624,185
-213,840
-2% -$1.46M 0.07% 276
2023
Q1 		$81.7M Sell
10,838,025
-176,837
-2% -$1.61M 0.09% 266
2022
Q4 		$112M Buy
11,014,862
+237,265
+2% +$2.74M 0.13% 205
2022
Q3 		$107M Buy
10,777,597
+10,699,753
+13,745% +$117M 0.13% 196
2022
Q2 		$829K Buy
+77,844
New +$659K ﹤0.01% 1525

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

VOYA Investment Management's ABCL Position: Q2 2025 in Review

VOYA Investment Management sold out of AbCellera Biologics (ABCL) in Q2 2025, closing a stake of 10,624,185 shares — an estimated $23.7M sold.

VOYA Investment Management first reported a position in ABCL in Q2 2022 and held it in 12 quarters. The position peaked at $112M in Q4 2022. 128 funds tracked by Wall St. Rank hold ABCL as of Q2 2025.

  • VOYA Investment Management reported no remaining AbCellera Biologics position as of Q2 2025 after selling out during the quarter.
  • VOYA Investment Management sold 10,624,185 AbCellera Biologics shares in Q2 2025, an estimated $23.7M.
  • VOYA Investment Management first reported a position in AbCellera Biologics in Q2 2022 and held it in 12 quarters.
  • VOYA Investment Management's AbCellera Biologics position peaked at $112M in Q4 2022.
  • 128 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2025.

Based on VOYA Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.